Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
13,263,019
-
Share change
-
-1,220,532
-
Total reported value
-
$53,050,012
-
Price per share
-
$4.00
-
Number of holders
-
58
-
Value change
-
-$8,594,243
-
Number of buys
-
33
-
Number of sells
-
17
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2018
As of 31 Mar 2018,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,263,019 shares.
The largest 10 holders included
BB BIOTECH AG, FMR LLC, INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, Prosight Management, LP, Aisling Capital LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Broadfin Capital, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.